Authors
Pedro A Lemos, Francesco Saia, Sjoerd H Hofma, Joost Daemen, Andrew TL Ong, Chourmouzios A Arampatzis, Angela Hoye, Eugene McFadden, Georgios Sianos, Pieter C Smits, Willem J van der Giessen, Pim de Feyter, Ron T van Domburg, Patrick W Serruys
Publication date
2004/2/18
Journal
Journal of the American College of Cardiology
Volume
43
Issue
4
Pages
704-708
Publisher
American College of Cardiology Foundation
Description
Objectives
This study investigated the clinical outcomes of patients with ST-segment elevation myocardial infarction (MI) treated with sirolimus-eluting stents (SESs) or with conventional bare stents.
Background
The clinical impact of SES implantation for patients with ST-segment elevation MI is currently unknown.
Methods
Primary angioplasty was performed with SESs in 186 consecutive patients with acute MI who were compared with 183 patients treated with bare stents. The incidence of death, reinfarction, and repeat revascularization was assessed at 30 and 300 days.
Results
Postprocedure vessel patency, enzymatic release, and the incidence of short-term adverse events were similar in both the sirolimus and the bare stents (30-day rate of death, reinfarction, or repeat revascularization: 7.5% vs. 10.4%, respectively; p = 0.4). Stent thrombosis was not diagnosed in any patient in the sirolimus group and occurred in 1 …
Total citations
Scholar articles
PA Lemos, F Saia, SH Hofma, J Daemen, ATL Ong… - Journal of the American College of Cardiology, 2004